COVID-19 | Specialty

The OncLive COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more.

Bekaii-Saab Highlights How COVID-19 Could Impact Future Practice

April 1st 2020

Tanios S. Bekaii-Saab, MD, FACP, discusses the shift toward telemedicine, the impact of protective strategies on the trajectory of COVID-19, and the potential aftereffects of the virus.

Dr. Carbone Provides Perspective on COVID-19

April 1st 2020

David P. Carbone, MD, PhD, director of the Thoracic Oncology Center at The Ohio State University Comprehensive Cancer Center–James, provides perspective on the novel coronavirus 2019 (COVID-19).

Charting New Territory in Multiple Myeloma Amid COVID-19 Crisis

March 31st 2020

Ajai Chari, MD, discusses the impact of the COVID-19 outbreak on hospital protocols and the measures that are being taken to reduce the spread of the virus.

Dr. Soto Perez de Celis on COVID-19 Risk Reduction

March 31st 2020

Enrique Soto Pérez de Celis, MD, MSc, a geriatric oncologist and researcher in the Department of Geriatrics at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City, Mexico, discusses ways to reduce the risk of contracting the novel coronavirus 2019 (COVID-19).

Lung Cancer Experts Share Insight on Rapidly Evolving COVID-19 Pandemic

March 30th 2020

Experts from Mayo Clinic, Ironwood Cancer and Research Centers, and Banner MD Anderson Cancer Center Clinic discuss the impact of the COVID-19 pandemic on cancer care and shared what advice they have been giving their patients.

Collaborative Efforts Lead to the Launch of the COVID-19 and Cancer Consortium Registry

March 30th 2020

Today, we passed the mic to Petros Grivas, MD, PhD, who moderated a discussion on a multi-institutional registry that has been created to capture data from healthcare professionals on patients with cancer who have suspected or confirmed diagnoses of the novel coronavirus, COVID-19. Joining Dr. Grivas is Jeremy L. Warner, MD, MS, as well as Ali R. Khaki, MD.

Scagliotti Speaks to Italy's Response to COVID-19 Outbreak

March 29th 2020

Giorgio Vittorio Scagliotti, MD, PhD, discusses the state of the healthcare system in Italy amongst the COVID-19 outbreak, techniques being implemented to "flatten the curve," and his outlook on the future after the pandemic.

Cancer Experts Come Together in the Fight Against Coronavirus

March 27th 2020

As the number of confirmed cases of COVID-19 continues to grow, oncologists from all over the world are working together to stay informed on the latest developments, participate in pivotal research efforts, develop potentially life-saving medications, and share personal experiences faced in practice to ultimately improve patient care.

Rini Shares Challenges in Keeping Up With COVID-19 in Oncology

March 27th 2020

Brian I. Rini, MD, highlights the Uromigos podcast efforts to educate other oncologists on how COVID-19 will shift their practice, as well as adapting to changing procedures in clinic to continue delivering optimal care for patients with cancer during the pandemic.

More Data Needed to Guide Cancer Care Decisions Amid COVID-19 Crisis

March 26th 2020

Petros Grivas, MD, discusses the repercussions of the COVID-19 pandemic on oncology practice patterns and the importance of contributing to the COVID-19 and Cancer Consortium Registry.

COVID-19 Causes Disruptions in Access to Care for Patients With Cancer

March 25th 2020

Omid Hamid, MD, discusses ongoing efforts to quell the COVID-19 pandemic, the benefits of telemedicine, and promising research being done to combat the virus.

From the Frontlines: Choueiri Talks Shift in GU Cancer Care in Wake of COVID-19

March 25th 2020

Toni K. Choueiri, MD, highlights the changes he has observed in clinical practice amidst the COVID-19 pandemic and the unified approach being taken at Dana-Farber Cancer Institute.

Dr. Chagpar on Limiting the Spread of COVID-19

March 25th 2020

Anees B. Chagpar, MD, MBA, MPH, FACS, FRCS(C), discusses the importance of taking proactive measures to prevent the spread of the novel 2019 coronavirus.

ASCO Meeting Goes Virtual Due to COVID-19

March 24th 2020

Due to COVID-19, the ASCO Annual Meeting will now occur using a virtual format.

UCSF Takes Steps to Stop COVID-19 Spread, Ensure Patient Safety

March 24th 2020

Thomas G. Martin, MD, discusses the risk of COVID-19 to patients with cancer and precautionary measures implemented by the the University of California San Francisco Helen Diller Family Comprehensive Cancer Center.

Dr. Hurvitz on Reducing Potential Exposure to COVID-19

March 23rd 2020

Sara A. Hurvitz, MD, associate professor at the David Geffen School of Medicine, University of California, Los Angeles (UCLA) medical director of the Jonsson Comprehensive Cancer Center Clinical Research Unit, co-director of the Santa Monica-UCLA Outpatient Oncology Practices, and director, Breast Cancer Clinical Trials Program, UCLA, discusses the steps that can be taken to reduce potential exposure to coronavirus disease 2019 (COVID-19).

FDA OKs Launch of Phase III Tocilizumab Trial for COVID-19 Pneumonia

March 23rd 2020

The FDA has approved the initiation of a double-blind, randomized phase III clinical trial of the oncology supportive care drug tocilizumab for use in combination with standard of care for the treatment of hospitalized adult patients with severe COVID-19 pneumonia.

Dr. Tripathy on Known Elements of COVID-19

March 21st 2020

Debu Tripathy, MD, professor and chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses known elements of COVID-19.

ASCO Speaks Out on COVID-19

March 21st 2020

Experts from ASCO detail the organization's response to the COVID-19 crisis and resources available for its members.

COVID-19 Is "Biggest Medical Issue" of Modern Times, Rugo Says

March 20th 2020

The need to establish preventive procedures that keep pace with the rapid evolution of coronavirus 2019 presents numerous challenges for the oncology field as institutions adapt standard treatment protocols to minimize the risk for virus spread among clinicians and patients alike.